Effect of some new beta-adrenergic blocking agents on certain metabolic responses to catecholamines.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001769:Blood; D001786:Blood Glucose; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D050356:Lipid Metabolism; D009206:Myocardium / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D001786:Blood Glucose; D005227:Fatty Acids; D013565:Sympatholytics; D007545:Isoproterenol; D011188:Potassium; D009638:Norepinephrine; D004837:Epinephrine